ID: MRFR/MED/4713-HCR | 100 Pages | Published By Kinjoll Dey on April 2023
The optical imaging market is expected to be of value USD 3.44 billion in 2030 and to grow at a 9.7% CAGR during the forecast 2022-2030. Optical imaging is a new technique that has a lot of promise for improving illness prevention, diagnosis, and treatment at the doctor's office or the operating room. Optical imaging has the ability to distinguish between soft tissues and damaged tissues. In the medical diagnosis sector, optical imaging's capacity to distinguish between healthy and infected tissues is providing a big potential.
Furthermore, compared to other adverse consequences of radiation-based imaging, optical imaging employs non-ionizing radiation, which considerably minimizes patient radiation exposure. This feature enables the patient to participate in research throughout.
However, issues such as complex regulatory approval procedures, expensive instrument prices, a lack of qualified operators, and insufficient reimbursement policies for optical imaging treatments limit the market growth.
Optical Imaging Market Segmentation
The optical imaging market is segmented on the basis of products, techniques, therapeutic area, application, and end-user.
Considering the type of product, the market is segmented into imaging systems, software, lenses, illumination systems, cameras and others. Imaging systems are further segmented into optical imaging systems and spectral imaging systems.
On the basis of technique, the optical imaging market is segmented into Optical Coherence Tomography (OCT), photoacoustic imaging, diffused optical tomography, hyperspectral imaging, near-infrared spectroscopy, and super-resolution microscopy.
On a therapeutic area basis, it is segmented into neurology, oncology, ophthalmology, dentistry, cardiology, dermatology, and others.
On account of application, the market is segmented into pre-clinical and clinical research, pathological imaging and intraoperative imaging.
According to the end-user, the market is segmented into diagnostic imaging centers, hospitals and clinics, research laboratories, and pharmaceutical &biotechnology companies.
Based on region the market is segmented into Americas, Europe, Asia Pacific, and the Middle East and Africa. Americas region is segmented into North America and South America. Similarly, Europe is segmented into Western Europe and Eastern Europe.
Regional Market Summary
In terms of geography, Americas dominates the market for optical imaging owing to increasing prevalence of cardiovascular, neurological and ophthalmic disorders about rising geriatric population which is a major trigger factor for this disease. Additionally, factors such as increasing government initiatives and funding for research in medical devices sector, rising demand for accurate diagnosis, awareness about adverse effects of radiation imaging, ability to provide in-depth images of soft tissues and vascular systems and presence of pharmaceutical giants key players also propel the market growth in this region. For instance, according to National cancer institute, in 2016, around 1,685,210 new cases of cancer were diagnosed in the U.S. Thus, this huge patient pool is going to boost up the market growth during the forecast period.
Europe is the second largest market and holds a healthy share in the global optical imaging market due to major driving factors like availability of advanced treatment facilities, increasing healthcare expenditure, good healthcare infrastructure and flourishing medical device industry due to the presence of major market players. Additionally, knowledge about the benefits of optical imaging over radiation imaging and capability of inhabitants to afford the diagnostics is spurring the market growth.
Asia Pacific is expected to be the fastest growing market with most promising growth possibilities. According to a report published by the department of neurology in 2014, it is estimated that for the current population of 1.27 billion, approximately 30 million people suffer from neurological disorders in India. Thus, owing to the huge patient pool, a faster adaptation of healthcare technology, government initiatives to increase the healthcare quality, availability favorable insurance policies market growth will be accelerated during the forecast period. Moreover, due to lower cost of clinical trials and research key players have been setting up their regional headquarters and manufacturing plants in Singapore, China, Japan, Korea, and Australia which make a positive growth curve in optical imaging market in future.
The Middle East & Africa is expected to show the least growth in the market due to some major factors such as lack of awareness, limited access and availability of treatment facilities. In the Middle East, the United Arab Emirates and Saudi Arabia is the largest market share owing to the development of healthcare industry and rising availability of specialty care centers. But market might show steady growth due to and government initiatives to improve quality of healthcare in this region.
Optical Imaging Market Share (%), by Region, 2017
Source: World Health Organization, Centers for Disease Control and Prevention, expert interview, annual report, white paper, company presentation and market research future analysis
Market Segmentation & Key players
Optical Imaging Market, by Product
Optical Imaging Market, by Techniques
Optical Imaging Market, by Therapeutic Area
Optical Technologies Market, by Applications
Optical Imaging Market, by End-user
Optical Imaging Market, By Region
North America
South America
Europe
Asia Pacific
Middle East and Africa
Optical Imaging Market Players
Recent Development
St. Jude Medical LLC (St. Jude Medical), a subsidiary of Abbott Laboratories, is a cardiovascular medical device researcher, manufacturer, and distributor. Atrial fibrillation, cardiac rhythm management, cardiovascular, and neuromodulation are the company's main target areas. The company's products include CRT devices, ICDs, remote monitoring systems, cardiac mapping and pacemakers, visualization systems, catheter-based ablation devices, spinal cord stimulation, structural heart products, peripheral nerve stimulation, and deep brain stimulation devices. Its gadgets are used in the fields of cardiovascular medicine, cardiac rhythm control, and atrial fibrillation treatment. St. Jude Medical is based in St. Paul, Minnesota, in the United States.
Headwall Photonics was created in 2003 as a consequence of a management buyout of Agilent Technologies' Holographic Grating Operation. Headwall is the world's leading maker of unique holographic diffraction gratings and optical modules. Industrial inspection, military and security, remote sensing, and biotechnology are some of the markets served by the company.Intended Audience
Report Attribute/Metric | Details |
---|---|
Market Size | USD 3.44 billion |
CAGR | 9.7% 2020-2030) |
Base Year | 2019 |
Forecast Period | 2020-2030 |
Historical Data | 2018 |
Forecast Units | Value (USD Million) |
Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
Segments Covered | Products, Techniques, Therapeutic Area, Application and End-Users |
Geographies Covered | North America, Europe, Asia-Pacific, and Rest of the World (RoW) |
Key Vendors | Jude Medical, Inc., Carl Zeiss Meditec AG, Bioptigen, Inc., Canon Inc, Heidelberg Engineering, Inc., Topcon Corporation, Perkinelmer, Inc., Koninklijke Philips N.V., Agfa-Gevaert N.V. |
Key Market Opportunities |
|
Key Market Drivers |
|
How much valuation would the optical imaging market attain until 2030
The optical imaging market would grow with 9.7% CAGR during the forecast period of 2020-2030
Factors like regulatory constraints, lack of skilled operators, high costs of instruments, and inadequate reimbursements policies can deter the optical imaging market growth.
North America, with its high investment capacity and technical superiority, would fetch the maximum global optical imaging market share.
The Asia Pacific region would register the fastest growth in the global optical imaging market.